Hersh Kozlov, Director at vTv Therapeutics Inc. (VTVT), bought 10,000 shares at $2.74 ($27K) on 2021-02-26, disclosed to the SEC on 2021-03-02.
Open-market purchase of $27k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VTVT | BUY | 2019-09-17 | $8K | — | Filing → |
| TBBK | SELL | 2018-03-01 | $53K | — | Filing → |
| TBBK | SELL | 2018-02-15 | $53K | — | Filing → |